Thanks Neuro. Autumn would put us in this range of cash remaining, which is getting on the low/fumes side of the spectrum - Aug - 8.0 mil Sep - 6.8 mil Oct - 5.6 mil Nov - 4.5 mil So you're expecting a financing to occur following the release of the RD results, but before an RD pharma deal can be inked?